Djamila Chaïb Eddour

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

Vincent Haufroid, Michel Mourad, Val rie Van Kerckhove et al. · Pharmacogenetics · 2004 · 445 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Correlation of Mycophenolic Acid Pharmacokinetic Parameters with Side Effects in Kidney Transplant Patients Treated with Mycophenolate Mofetil

Michel Mourad, Jacques Malaise, Djamila Chaïb Eddour et al. · Clinical Chemistry · 2001 · 190 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study

Vincent Haufroid, Pierre Wallemacq, V. VanKerckhove et al. · American Journal of Transplantation · 2006 · 181 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Sirolimus and Tacrolimus Trough Concentrations and Dose Requirements after Kidney Transplantation in Relation to CYP3A5 and MDR1 Polymorphisms and Steroids

Michel Mourad, Georges Mourad, Pierre Wallemacq et al. · Transplantation · 2005 · 114 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetic Basis for the Efficient and Safe Use of Low-Dose Mycophenolate Mofetil in Combination with Tacrolimus in Kidney Transplantation

Michel Mourad, Jacques Malaise, Djamila Chaïb Eddour et al. · Clinical Chemistry · 2001 · 110 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17